Antimicrobial Susceptibility Testing Market Worth $5.99 Billion by 2028
Meticulous
Research®– a leading global market research company published a research report
titled “Antimicrobial
Susceptibility Testing Market,
by Product (Manual {Susceptibility Discs, Plates, MIC Strips}, Consumables,
Automated), Method (Diffusion, Dilution), Application (Clinical Diagnostics),
End User (Hospitals, Pharma, Institutes) - Forecast to 2028.”
Download
free sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5062?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=12-02-2024
According
to this latest publication from Meticulous Research®, the Antimicrobial
Susceptibility Testing Market is expected to reach $5.99 billion by 2028, at a
CAGR of ~6.4% during the forecast period. Some of the major factors driving the
growth of the market include the high prevalence of infectious diseases,
development of automated AST products, increasing government initiatives and
funding towards antimicrobial susceptibility testing programs, technological
advancements towards the development of new AST methods, and the emergence of
multidrug resistance in microorganisms. However, stringent government
regulations are expected to hinder the growth of this market to a certain
extent. Emerging markets and active R&D to develop rapid antimicrobial
susceptibility testing are expected to offer significant growth opportunities
for players operating in the antimicrobial susceptibility testing market.
Antimicrobial
Susceptibility Testing Market: Future Outlook
The
Antimicrobial Susceptibility Testing Market study presents historical market
data in terms of values (2019 and 2020), estimated current data (2021), and
forecasts for 2028- by Product (Manual AST Products {Susceptibility Discs,
Susceptibility Plates, and MIC Strips}, Consumables, and Automated AST
Products), Method (Disk Diffusion, Automated AST, Dilution, and Other Methods),
Application (Clinical Diagnostics, Drug Discovery and Development, Other
Applications), End User (Diagnostic Laboratories & Hospitals,
Pharmaceutical and Biotechnology Companies, Research and Academic Institutes).
The antimicrobial susceptibility testing market study also evaluates industry
competitors and analyzes the market at regional and country levels.
Based
on product, the antimicrobial susceptibility testing market is segmented into
manual antimicrobial susceptibility testing products, automated antimicrobial
susceptibility testing products, and consumables. In 2021, the manual
antimicrobial susceptibility testing products segment is expected to account
for the largest share of the antimicrobial susceptibility testing market. The
growth in this market is driven by and the low cost of the manual AST products
and simple handling procedures. Availability of a diverse range of consumables
for manual testing and easy interpretation of tests are further propelling the
growth of this segment.
Based
on method, the disk diffusion segment is expected to account for the largest
share of the antimicrobial susceptibility testing market in 2021. The low cost
associated with performing AST testing with the disk diffusion method and
developments in the disk diffusion method with the use of automated technology
is primarily boosting the segment growth.
Speak to
analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5062?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=12-02-2024
Based
on application, the clinical diagnostics segment is expected to account for the
largest share of the antimicrobial susceptibility testing market in 2021 due to
the rising burden of antimicrobial resistance and growing awareness about the
use of antimicrobial susceptibility testing methods.
This
research report analyzes major geographies and provides comprehensive analysis
for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy,
Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of
Asia-Pacific), Latin America, and the Middle East & Africa. North America
is expected to account for the largest share of the antimicrobial
susceptibility testing market in 2021, followed by Europe and Asia-Pacific.
Factors driving the North American market include the adoption of
technologically advanced susceptibility testing methods and continuous research
for new drugs using ASTs, along with the awareness about treatment options.
The
key players operating in the antimicrobial susceptibility testing market are
Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad
Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and
Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd.
(India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc.
(U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.),
and Zhuhai DL Biotech Co., Ltd (China), among others.
Key
questions answered in the report-
· Which
are the high growth market segments in terms of product, method, application,
end user, and regions/countries?
· What
was the historical market for antimicrobial susceptibility testing across the
globe?
· What
are the market forecasts and estimates for the period 2021-2028?
· What
are the major drivers, restraints, challenges, and opportunities in the
antimicrobial susceptibility testing market?
· Who
are the major players in the antimicrobial susceptibility testing market?
· How
is the competitive landscape and who are the market leaders in the
antimicrobial susceptibility testing market?
· What
are the recent developments in the antimicrobial susceptibility testing market?
· What
are the different strategies adopted by the major players in the antimicrobial
susceptibility testing market?
· What
are the geographical trends and high growth regions/ countries?
Contact
Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment